Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity

被引:66
|
作者
Majumdar, Papiya [1 ]
Bathula, Chandramohan [2 ]
Basu, Suparna M. [1 ]
Das, Subhendu K. [1 ]
Agarwal, Rahul [3 ]
Hati, Santanu [2 ]
Singh, Ashutosh [3 ]
Sen, Subhabrata [2 ]
Das, Benu Brata [1 ]
机构
[1] Indian Assoc Cultivat Sci, Dept Phys Chem, Mol Biol Lab, Kolkata 700032, India
[2] Shiv Nadar Univ, Dept Chem, Gautam Buddha Nagar 201314, Uttar Pradesh, India
[3] Shiv Nadar Univ, Dept Life Sci, Gautam Buddha Nagar 201314, Uttar Pradesh, India
基金
英国惠康基金;
关键词
Topoisomerase I; Thiohydantoin; Hydantoin; Methylfuro[3,4-c]pyridine-3,4(1H,5H)-dione; Camptothecin; Leishmania bi-subunit topoisomerase I; DNA TOPOISOMERASES; LEISHMANIA; SUBUNIT; CAMPTOTHECIN; HYDANTOIN; TDP1; DISCOVERY; REPAIR;
D O I
10.1016/j.ejmech.2015.08.032
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:540 / 551
页数:12
相关论文
共 50 条
  • [31] New Benzimidazole-Triazole Derivatives as Topoisomerase I Inhibitors: Design, Synthesis, Anticancer Screening, and Molecular Modeling Studies
    Cevik, Ulviye Acar
    Kaya, Betul
    Celik, Ismail
    Rudrapal, Mithun
    Rakshit, Gourav
    Karayel, Arzu
    Levent, Serkan
    Osmaniye, Derya
    Ozkan, Begum Nurpelin Saglik
    Baysal, Merve
    Atli Ekliog''lu, Ozlem
    O''zkay, Yusuf
    Kaplancikli, Zafer Asim
    ACS OMEGA, 2024, 9 (11): : 13359 - 13372
  • [32] Design, synthesis and biological evaluation of tetracyclic azafluorenone derivatives with topoisomerase I inhibitory properties as potential anticancer agents
    Chen, Tsung-Chih
    Yu, Dah-Shyong
    Chen, Shiag-Jiun
    Chen, Chun-Liang
    Lee, Chia-Chung
    Hsieh, Ying-Yu
    Chang, Lien-Cheng
    Guh, Jih-Hwa
    Lin, Jing-Jer
    Huang, Hsu-Shan
    ARABIAN JOURNAL OF CHEMISTRY, 2019, 12 (08) : 4348 - 4364
  • [33] Design, synthesis, and antitumor evaluation of sophoridine derivatives as topoisomerase I inhibitors based on the topomer CoMFA model
    Zhang, Ya-Kun
    Tong, Jian-Bo
    Zhang, Hong-Yan
    Luo, Mu-Xuan
    Qing, Zhi-Peng
    Tan, Cheng-Jian
    JOURNAL OF MOLECULAR STRUCTURE, 2025, 1335
  • [34] Design of new topoisomerase I inhibitors: Synthesis and in vitro activity.
    Minchera, DJ
    Kaya, G
    Pettersson, S
    Turnbull, A
    Bibby, MC
    BRITISH JOURNAL OF CANCER, 2001, 85 : 92 - 92
  • [35] A new scaffold of topoisomerase I inhibitors: Design, synthesis and biological evaluation
    Mazza, Alberto
    Beccalli, Egle M.
    Contini, Alessandro
    Garcia-Argaez, Aida Nelly
    Via, Lisa Dalla
    Gelmi, Maria Luisa
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 124 : 326 - 339
  • [36] Synthesis and Biological Evaluation of 7-Alkenyl Homocamptothecins as Potent Topoisomerase I Inhibitors
    Zhu, Lingjian
    Zhang, Xianghua
    Lei, Ning
    Liu, Wenfeng
    Miao, Zhenyuan
    Zhuang, Chunlin
    Sheng, Chunquan
    Guo, Wei
    Dong, Guoqiang
    Yao, Jianzhong
    Cheng, Pengfei
    Zhang, Wannian
    CHEMISTRY & BIODIVERSITY, 2012, 9 (06) : 1084 - 1094
  • [37] Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes
    Das, Subhendu K.
    Ghosh, Arijit
    Chowdhuri, Srijita Paul
    Halder, Nyancy
    Rehman, Ishita
    Sengupta, Souvik
    Sahoo, Krushna Chandra
    Rath, Harapriya
    Das, Benu Brata
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (03) : 804 - 817
  • [38] Design and synthesis of new quinoline derivatives as selective C-RAF kinase inhibitors with potent anticancer activity
    Zaraei, Seyed-Omar
    Al-Ach, Nour N.
    Anbar, Hanan S.
    El-Gamal, Randa
    Tarazi, Hamadeh
    Tokatly, Rimas T.
    Kalla, Rawan R.
    Munther, Mouna A.
    Wahba, Marwa M.
    Alshihabi, Aya M.
    Shehata, Mahmoud K.
    Sbenati, Rawan M.
    Shahin, Afnan I.
    El-Awady, Raafat
    Al-Tel, Taleb H.
    El-Gamal, Mohammed I.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 238
  • [39] Topoisomerase I (TOP1) dynamics: conformational transition from open to closed states
    Diane T. Takahashi
    Danièle Gadelle
    Keli Agama
    Evgeny Kiselev
    Hongliang Zhang
    Emilie Yab
    Stephanie Petrella
    Patrick Forterre
    Yves Pommier
    Claudine Mayer
    Nature Communications, 13
  • [40] Topoisomerase I (TOP1) dynamics: conformational transition from open to closed states
    Takahashi, Diane T.
    Gadelle, Daniele
    Agama, Keli
    Kiselev, Evgeny
    Zhang, Hongliang
    Yab, Emilie
    Petrella, Stephanie
    Forterre, Patrick
    Pommier, Yves
    Mayer, Claudine
    NATURE COMMUNICATIONS, 2022, 13 (01)